CClinicalTrials.gg
CompletedNCT03845465T1DUpdated Mar 21, 2025Results posted

Positive Psychology Intervention to Treat Diabetes Distress in Teens With Type 1 Diabetes

An interventional study of Positive Affect + Education and Education in Type 1 Diabetes Mellitus, sponsored by Vanderbilt University Medical Center. Completed at 2 sites in United States. Open to participants aged 13 Years to 17 Years. Per ClinicalTrials.gov, last updated 2025-03-21.

Sponsored by Vanderbilt University Medical Center · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
400
Allocation
Randomized
Ages
13 Years to 17 Years
Sex
All
01

Study summary

The treatment regimen for type 1 diabetes is complex and demanding, and many adolescents experience diabetes distress related to the daily demands of diabetes care, which can cause problems with diabetes management and glycemic control. The proposed study will conduct a multisite, randomized trial to test the effects of a positive psychology intervention aimed at treating diabetes distress and improving glycemic outcomes. The potential benefits include helping adolescents achieve better glycemic control, improved self-management, and psychosocial outcomes

Read the detailed description

Adolescents with type 1 diabetes (T1D) struggle to meet treatment goals - only 17% met the target for glycemic control in a recent national study - and many adolescents experience high levels of diabetes distress related to the daily demands of diabetes care. Yet, previous interventions to improve glycemic control in adolescents with type 1 diabetes have only shown modest to moderate effects, and many have been time-intensive and expensive. Thus, there is a need for novel interventions to improve outcomes in adolescents with T1D. Increasing positive affect, or pleasurable engagement with the environment (e.g., feeling happy, cheerful, proud), has been shown to promote the use of more adaptive coping strategies to manage stress. Thus, the proposed study is based on the premise that, by boosting positive affect in teens with diabetes, we will enhance the use of adaptive coping strategies and reduce diabetes distress, thereby improving glycemic control in adolescents. Through an iterative series of pilot studies, our research team adapted a behavioral intervention using a positive psychology framework that we demonstrated to be feasible and acceptable for adolescents with T1D. This intervention is aimed at inducing positive affect in adolescents (age 13-17) through empirically-validated, tailored exercises in gratitude, self-affirmation, and caregiver affirmations. In our pilot studies, the intervention had promising effects on adolescents' quality of life, diabetes-related stress, and family conflict, all of which are closely linked with diabetes distress. We now plan to evaluate the efficacy of the intervention in a multisite, randomized controlled trial. The aims of this study are to 1) evaluate the effects of a positive psychology intervention for adolescents (age 13-17) and their caregivers on glycemic control; 2) evaluate the effects of the intervention on diabetes distress, coping, and self-care behavior; and 3) explore the differential impact of intervention effects across demographic and treatment variables. We plan to randomize 200 adolescent-caregiver dyads to the Positive Affect + Education intervention (n=100) or the Education only intervention (n=100) from two clinical sites (Vanderbilt University Medical Center and Children's National Medical Center). By employing a positive psychology framework, we propose an innovative approach to treat diabetes distress and improve glycemic outcomes. We believe this novel intervention has the potential to improve outcomes in adolescents with T1D, and the use of automated text messaging to deliver the intervention offers possibilities for wide dissemination.

02

Conditions studied

  • Type 1 Diabetes Mellitus
03

In context

Diabetes Mellitus

10,925 studies on the registry are indexed under Diabetes Mellitus; 1,319 are open to participants now.

This study's enrollment of 400 is above the median of 80 across 8,367 interventional studies indexed under Diabetes Mellitus.

Browse Diabetes Mellitus studies →

Lead sponsor

Vanderbilt University Medical Center is the lead sponsor of 824 studies on the registry; 164 are open to participants now.

Of its 122 completed or terminated interventional studies of FDA-regulated products, 91 (75%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
13 Years to 17 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Age 13-17
  • Diagnosed with type 1 diabetes for at least 12 months
  • Speak and read English
  • Report at least moderate diabetes distress on the Problem Areas in Diabetes Scale - Teen version

Exclusion criteria

Exclusion Criteria:

  • Other serious health conditions
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Investigator)
Enrollment
400 participants (actual)

Study arms

  • Active comparator
    Education

    Participants in the Education group will complete a behavioral health contract and will receive an educational packet.

    Behavioral: Education

  • Experimental
    PA + Education

    Participants in the Positive Affect + Education group will complete a behavioral health contract and receive an educational packet. In addition, they will receive intervention components aimed at inducing positive affect.

    Behavioral: Positive Affect + Education · Behavioral: Education

Interventions

  • BehavioralPositive Affect + Education

    Adolescents will complete a health behavior contract and receive an educational packet at baseline. Adolescents will complete a positive affect interview at baseline. They will receive automated text messages 5 days/week for 8 weeks. Messages will be tailored to include adolescents' responses to the baseline interview, including reminders to engage in gratitude and self-affirmation. Additionally, to induce positive mood they will be texted gift cards codes valued at $5.00. Further, caregivers will be asked to provide weekly positive affirmations to their adolescents, focused on non-diabetes strengths.

  • BehavioralEducation

    Adolescents will complete a health behavior contract and receive an educational packet with information about diabetes management.

06

What researchers measure

Primary outcomes

  1. Hemoglobin A1c

    Hemoglobin A1c measures the amount of glucose attached to hemoglobin. It is assessed as part of regular diabetes clinic visits. The target is \<7.0%.

    Time frame: 3 months

Secondary outcomes

  1. Diabetes Distress

    The Problem Area In Diabetes - Teen (PAID-T) measures diabetes distress. Scores range from 14-84, with higher scores indicated greater distress. A total score of 44 or higher is considered clinically significant.

    Time frame: 3 months

  2. Primary Control Coping

    Responses to Stress Questionnaire measures coping with diabetes-related stress. Three factors of coping are measured: primary control coping, secondary control coping,and disengagement coping. A ratio score is calculated to determine the ratio of each type of coping in relation to total coping, ranging from 0.00 to 1.00. Higher scores indicate greater relative use of primary control coping (e.g., problem solving, emotional modulation).

    Time frame: 3 months

  3. Secondary Control Coping

    Responses to Stress Questionnaire measures coping with diabetes-related stress. Three factors of coping are measured: primary control coping, secondary control coping,and disengagement coping. A ratio score is calculated to determine the ratio of each type of coping in relation to total coping, ranging from 0.00 to 1.00. Higher levels indicate greater relative use of secondary control coping (e.g., acceptance, distraction, positive thinking).

    Time frame: 3 months

  4. Disengagement Coping

    Responses to Stress Questionnaire measures coping with diabetes-related stress. Three factors of coping are measured: primary control coping, secondary control coping,and disengagement coping. A ratio score is calculated to determine the ratio of each type of coping in relation to total coping, ranging from 0.00 to 1.00. Higher levels indicate greater relative use of disengagement coping (e.g., avoidance, denial).

    Time frame: 3 months

  5. Positive Affect

    Positive affect measured using the Positive and Negative Affect Scale for children (PANAS-C). The positive affect scale consists of 15 items, which are summed for a total score, ranging from 15-60. Higher scores indicate higher levels of positive affect.

    Time frame: 3 months

  6. Diabetes Self-Care Behavior

    The Self Care Inventory measures adherence to the recommended diabetes treatment regimen. Adolescents and parents report on the adolescents' self-care behaviors. A mean score is calcuated, ranging from 1-5. Higher scores indicate higher levels of self-management behaviors.

    Time frame: 3 months

  7. Diabetes-Related Quality of Life

    Type 1 Diabetes and Life measures adolescents self-reported diabetes-related quality of life. Scores range from 0-100, and higher scores indicate better quality of life.

    Time frame: 3 months

07

Results

Posted Mar 21, 2025

Participant flow

Recruited from pediatric diabetes clinics at Vanderbilt University Medical Center and Children's National Hospital.

Baseline Through Intervention
Participant flow — Baseline Through Intervention
MilestoneEducationPA + Education
Started198198
Caregivers9999
Adolescents9999
Completed194198
Not completed40
Withdrew: Withdrawal by subject40
3-month Data Collection
Participant flow — 3-month Data Collection
MilestoneEducationPA + Education
Started194198
Caregivers9799
Adolescents9799
Completed194198
Not completed00
6-month Data Collection
Participant flow — 6-month Data Collection
MilestoneEducationPA + Education
Started194198
Caregivers9799
Adolescents9799
Completed194196
Not completed02
Withdrew: Withdrawal by subject02
12-month Data Collection
Participant flow — 12-month Data Collection
MilestoneEducationPA + Education
Started194196
Caregivers9798
Adolescents9798
Completed194194
Not completed02
Withdrew: Withdrawal by subject02

Outcome measures

PrimaryHemoglobin A1c

Hemoglobin A1c measures the amount of glucose attached to hemoglobin. It is assessed as part of regular diabetes clinic visits. The target is \<7.0%.

Time frame:
3 months
Reported as:
Mean · Percentage of glycated hemoglobin
Hemoglobin A1c
Percentage of glycated hemoglobinEducationPA + Education
Hemoglobin A1c9.0 ± 2.09.0 ± 2.4
SecondaryDiabetes Distress

The Problem Area In Diabetes - Teen (PAID-T) measures diabetes distress. Scores range from 14-84, with higher scores indicated greater distress. A total score of 44 or higher is considered clinically significant.

Time frame:
3 months
Reported as:
Mean · score on a scale
Diabetes Distress
score on a scaleEducationPA + Education
Diabetes Distress43 ± 1645 ± 14
SecondaryPrimary Control Coping

Responses to Stress Questionnaire measures coping with diabetes-related stress. Three factors of coping are measured: primary control coping, secondary control coping,and disengagement coping. A ratio score is calculated to determine the ratio of each type of coping in relation to total coping, ranging from 0.00 to 1.00. Higher scores indicate greater relative use of primary control coping (e.g., problem solving, emotional modulation).

Time frame:
3 months
Reported as:
Median · ratio score
Primary Control Coping
ratio scoreEducationPA + Education
Primary Control Coping.16 (.14 to .18).16 (.13 to .18)
SecondarySecondary Control Coping

Responses to Stress Questionnaire measures coping with diabetes-related stress. Three factors of coping are measured: primary control coping, secondary control coping,and disengagement coping. A ratio score is calculated to determine the ratio of each type of coping in relation to total coping, ranging from 0.00 to 1.00. Higher levels indicate greater relative use of secondary control coping (e.g., acceptance, distraction, positive thinking).

Time frame:
3 months
Reported as:
Median · ratio score
Secondary Control Coping
ratio scoreEducationPA + Education
Secondary Control Coping.24 (.20 to .27).23 (.21 to .26)
SecondaryDisengagement Coping

Responses to Stress Questionnaire measures coping with diabetes-related stress. Three factors of coping are measured: primary control coping, secondary control coping,and disengagement coping. A ratio score is calculated to determine the ratio of each type of coping in relation to total coping, ranging from 0.00 to 1.00. Higher levels indicate greater relative use of disengagement coping (e.g., avoidance, denial).

Time frame:
3 months
Reported as:
Median · ratio score
Disengagement Coping
ratio scoreEducationPA + Education
Disengagement Coping.16 (.14 to .17).16 (.14 to .18)
SecondaryPositive Affect

Positive affect measured using the Positive and Negative Affect Scale for children (PANAS-C). The positive affect scale consists of 15 items, which are summed for a total score, ranging from 15-60. Higher scores indicate higher levels of positive affect.

Time frame:
3 months
Reported as:
Mean · score on a scale
Positive Affect
score on a scaleEducationPA + Education
Positive Affect41 ± 1144 ± 11
SecondaryDiabetes Self-Care Behavior

The Self Care Inventory measures adherence to the recommended diabetes treatment regimen. Adolescents and parents report on the adolescents' self-care behaviors. A mean score is calcuated, ranging from 1-5. Higher scores indicate higher levels of self-management behaviors.

Time frame:
3 months
Reported as:
Mean · score on a scale
Diabetes Self-Care Behavior
score on a scaleEducationPA + Education
Diabetes Self-Care Behavior3.74 ± 0.653.72 ± 0.68
SecondaryDiabetes-Related Quality of Life

Type 1 Diabetes and Life measures adolescents self-reported diabetes-related quality of life. Scores range from 0-100, and higher scores indicate better quality of life.

Time frame:
3 months
Reported as:
Mean · score on a scale
Diabetes-Related Quality of Life
score on a scaleEducationPA + Education
Diabetes-Related Quality of Life52 ± 1452 ± 14

Adverse events

Collected over Adverse event data were collected for the active study period (4 years).. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Education0/99 (0%)0/99 (0%)0/99 (0%)
PA + Education0/99 (0%)0/99 (0%)0/99 (0%)

Baseline characteristics

Participants were caregiver-adolescent dyads.

Age, Continuous
Age, Continuous(years)EducationPA + EducationTotal
Adolescent Age15.4 ± 1.415.3 ± 1.415.3 ± 1.4
Caregiver Age46.1 ± 7.145.3 ± 7.645.7 ± 7.3
Sex: Female, Male
Sex: Female, Male(Participants)EducationPA + EducationTotal
Adolescent Sex — Female5758115
Adolescent Sex — Male424183
Caregiver Sex — Female8485169
Caregiver Sex — Male141428
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)EducationPA + EducationTotal
Adolescent Ethnicity — Hispanic or Latino729
Adolescent Ethnicity — Not Hispanic or Latino9297189
Adolescent Ethnicity — Unknown or Not Reported000
Caregiver Ethnicity — Hispanic or Latino527
Caregiver Ethnicity — Not Hispanic or Latino9395188
Caregiver Ethnicity — Unknown or Not Reported123
Race (NIH/OMB)
Race (NIH/OMB)(Participants)EducationPA + EducationTotal
Adolescent Race — American Indian or Alaska Native112
Adolescent Race — Asian358
Adolescent Race — Native Hawaiian or Other Pacific Islander000
Adolescent Race — Black or African American232447
Adolescent Race — White6360123
Adolescent Race — More than one race8816
Adolescent Race — Unknown or Not Reported112
Caregiver Race — American Indian or Alaska Native112
Caregiver Race — Asian369
Caregiver Race — Native Hawaiian or Other Pacific Islander011
Caregiver Race — Black or African American212041
Caregiver Race — White7067137
Caregiver Race — More than one race235
Caregiver Race — Unknown or Not Reported213
Region of Enrollment
Region of Enrollment(participants)EducationPA + EducationTotal
United States9999198
Region of Enrollment
Region of Enrollment(participants)EducationPA + EducationTotal
United States9999198
Diabetes Distress (PAID-T)
Diabetes Distress (PAID-T)(score on a scale)EducationPA + EducationTotal
Mean48.4 ± 10.348.3 ± 10.748.4 ± 10.5
HbA1c
HbA1c(percentage of glycated hemoglobin)EducationPA + EducationTotal
Mean9.4 ± 2.08.9 ± 2.39.1 ± 2.1
08

Study locations

2 sites
  • Children's National
    Washington, District of Columbia 20010, United States
  • Vanderbilt University Medical Center
    Nashville, Tennessee 37232, United States
09

References and documents

Study documents

  • Protocol and statistical analysis plan · Apr 11, 2023

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 21, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT03845465
Lead sponsor
Vanderbilt University Medical Center
Collaborators
Children's National Research Institute
Responsible party
Sarah Jaser (Associate Professor, Vanderbilt University Medical Center) — Principal investigator
First posted
Feb 19, 2019
Start date
Dec 17, 2019
Primary completion
Aug 23, 2023
Completion
Sep 7, 2023
Results posted
Mar 21, 2025
Last update
Mar 21, 2025

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion